Delivery Order SPE2DB25D7056-SPE2DB25FTNCQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,623.32 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis...
- The Defense Logistics Agency awarded a $2,570.68 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Rifampin 300 mg capsules (60 count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $8,102.57. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Rifampin 150 mg capsules in quantities of 30 units. This firm fixed-price delivery order, valued at $4,363.44, is non-set-aside and represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for Rifampin 150 mg capsules (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order valued at $5,984.18 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Rifampin 300 mg capsules in unit dose packages of 100 units. This competitively awarded contract, valued at $2,276.64 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The order is scheduled for completion by August 18, 2025, with fulfillment performed at the contractor's facility in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. This firm fixed-price delivery order carries a ceiling value of $7,920.22 and is scheduled for ultimate completion by July 23, 2025. The contract represents a non-competitive, non-set-aside award with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed-price contract with a ceiling value of $3,733.05. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive procurement. Performance of this delivery order will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Rifampin 300 mg capsules (60-count units) valued at $3,232.50 under firm fixed pricing. The order is non-set-aside and will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTNCQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Rifampin 150 mg capsules in quantities of 30 units, with a contract ceiling value of $2,001.28 and an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis and other mycobacterial infections, representing essential pharmaceutical inventory for military and federal healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of medications and medical commodities to support military healthcare programs globally through this prime contract vehicle. The company's established track record of fulfilling diverse federal pharmaceutical procurement requirements through open competition demonstrates its capability to meet stringent federal supply standards for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/2/25 |